SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-22-015208
Filing Date
2022-06-21
Accepted
2022-06-21 06:06:57
Documents
9
Period of Report
2022-07-28

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 6662
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 5930
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 8807
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 157577
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 710
6 EXHIBIT 99.5 exhibit99-5.htm EX-99.5 537
7 GRAPHIC exhibit99-4xu001.jpg GRAPHIC 173725
8 GRAPHIC exhibit99-4xu002.jpg GRAPHIC 125166
9 GRAPHIC exhibit99-5xu001.jpg GRAPHIC 123472
  Complete submission text file 0001062993-22-015208.txt   763541
Mailing Address SUITE 820, 1075 WEST GEORGIA STREET VANCOUVER A1 V6E 3N9
Business Address SUITE 820, 1075 WEST GEORGIA STREET VANCOUVER A1 V6E 3N9 604-336-8613
C21 Investments Inc. (Filer) CIK: 0000831609 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0131
Type: 6-K | Act: 34 | File No.: 000-55982 | Film No.: 221025872
SIC: 2833 Medicinal Chemicals & Botanical Products